Literature DB >> 22521320

Does treatment affect the levels of serum interleukin-6, interleukin-8 and procalcitonin in diabetic foot infection? A pilot study.

Fatma Aybala Altay1, İrfan Sencan, Gönül Çiçek Şentürk, Mustafa Altay, Selda Güvenman, Selman Ünverdi, Ziya Cibali Açıkgöz.   

Abstract

AIMS: To investigate about serum PCT, IL-6 and IL-8 levels and how they are affected by the treatment in diabetic foot patients.
METHODS: Fifty patients' blood samples were taken to study ESR and CRP, IL-6, IL-8 and PCT before and at the 14th day of the treatment.
RESULTS: The pretreatment results of the 50 patients showed positive correlations between PCT and either ESH (r=0.49, p<0.001), or CRP (r=0.56, p<0.001). Similarly, there was a positive correlation between IL-6 and ESH (r=0.46, p=0.001), just like as it was between IL-6 and CRP (r=0.54, p<0.001). At the 14th day, the levels of ESR (70 ± 30.2 and 58.4 ± 26.2, p=0.02), CRP (63.8 ± 73.1 and 18.1 ± 19.7, p<0.001) and PCT (0.6 ± 2.1 and 0.05 ± 0.02, p=0.007) were significantly decreased while IL-6 was decreased at a close range to statistical significancy at healing patients (97.5 ± 147.2 and 47.1 ± 77.6; p=0.05), but they did not at nonhealing patients. IL-8 levels were not changed anyhow.
CONCLUSIONS: PCT was significantly decreased such as ESR and CRP were in the early phase of healing; IL-6 and IL-8 levels were also decreased by the treatment, but not statistically significantly. IL-6 and PCT were affected in correlation with the other inflammatory parameters in the beginning, but IL-8 was not. PCT and IL-6 may be useful like CRP and ESR in the diagnosis and follow up of diabetic foot infection, but IL-8 is not. Further investigation is needed.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521320     DOI: 10.1016/j.jdiacomp.2012.03.018

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  7 in total

Review 1.  The microbiologic profile of diabetic foot infections in Turkey: a 20-year systematic review: diabetic foot infections in Turkey.

Authors:  M Hatipoglu; M Mutluoglu; G Uzun; E Karabacak; V Turhan; B A Lipsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-23       Impact factor: 3.267

2.  The value of inflammatory markers to diagnose and monitor diabetic foot osteomyelitis.

Authors:  Suzanne Av Van Asten; Adam Nichols; Javier La Fontaine; Kavita Bhavan; Edgar Jg Peters; Lawrence A Lavery
Journal:  Int Wound J       Date:  2015-12-03       Impact factor: 3.315

3.  An Alteration of Lymphocytes Subpopulations and Immunoglobulins Levels in Patients with Diabetic Foot Ulcers Infected Particularly by Resistant Pathogens.

Authors:  Vladimíra Fejfarová; Alexandra Jirkovská; Michal Dubský; Frances Game; Jana Vydláková; Alena Sekerková; Jana Franeková; Monika Kučerová; Ilja Stříž; Vladimír Petkov; Robert Bém; Veronika Wosková; Andrea Němcová; Jelena Skibová
Journal:  J Diabetes Res       Date:  2016-12-05       Impact factor: 4.011

4.  Cost of illness among patients with diabetic foot ulcer in Turkey.

Authors:  Ergun Oksuz; Simten Malhan; Bilge Sonmez; Rukiye Numanoglu Tekin
Journal:  World J Diabetes       Date:  2016-10-15

5.  The Role of Serum Procalcitonin, Interleukin-6, and Fibrinogen Levels in Differential Diagnosis of Diabetic Foot Ulcer Infection.

Authors:  Pınar Korkmaz; Havva Koçak; Kevser Onbaşı; Polat Biçici; Ahmet Özmen; Cemile Uyar; Duru Mıstanoğlu Özatağ
Journal:  J Diabetes Res       Date:  2018-02-21       Impact factor: 4.011

6.  Role of Procalcitonin as a Predictor of Clinical Outcome in Acute Diabetic Foot Infections: A Prospective Study.

Authors:  Adlyne R Asirvatham; Usha Menon; Praveen V Pavithran; Jayakumar R Vasukutty; Harish Kumar; Nisha Bhavani; Arun Menon; Vasantha Nair; Vivek Lakshmanan; Ajit K Varma; Mangalanandan T Sukumaran; Arun Bal
Journal:  Indian J Endocrinol Metab       Date:  2019 Jan-Feb

7.  Predictive Value of Soluble CD14, Interleukin-6 and Procalcitonin For Lower Extremity Amputation in People with Diabetes with Foot Ulcers: A Pilot Study.

Authors:  Ahmet Karakas; Erol Arslan; Tolga Cakmak; Ibrahim Aydin; E Ozgur Akgul; Seref Demirbas
Journal:  Pak J Med Sci       Date:  2014-05       Impact factor: 1.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.